{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:52:08Z","timestamp":1792716728683,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Anesthesia"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jclinane.2026.112156","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:47:37Z","timestamp":1772610457000},"page":"112156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Safety and efficacy of Suzetrigine (VX-548) for acute moderate to severe pain in adults; a systematic review and meta-analysis"],"prefix":"10.1016","volume":"111","author":[{"given":"Qunoot","family":"Irfan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Muhammad Mehdi","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Zohair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laraib","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Hassan","family":"Alvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jclinane.2026.112156_bb0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1213\/01.ane.0000267526.37663.41","article-title":"Recognizing pain management as a human right: a first step","volume":"105","author":"Fishman","year":"2007","journal-title":"Anesth Analg [Internet]"},{"key":"10.1016\/j.jclinane.2026.112156_bb0015","article-title":"Pain as a global public health priority","volume":"11","author":"Goldberg","year":"2011","journal-title":"BMC Public Health [Internet]"},{"issue":"6","key":"10.1016\/j.jclinane.2026.112156_bb0020","first-page":"S7","article-title":"Acute pain in perspective","volume":"72","author":"McCarberg","year":"2023","journal-title":"J Fam Pract [Internet]"},{"issue":"1","key":"10.1016\/j.jclinane.2026.112156_bb0025","article-title":"Drugs in development to manage acute pain","volume":"85","author":"Oliver","year":"2024","journal-title":"Drugs [Internet]"},{"issue":"9169","key":"10.1016\/j.jclinane.2026.112156_bb0030","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(99)03313-9","article-title":"Acute pain","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet [Internet]"},{"key":"10.1016\/j.jclinane.2026.112156_bb0035","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.2147\/JPR.S144066","article-title":"Poorly controlled postoperative pain: prevalence, consequences, and prevention","volume":"10","author":"Gan","year":"2017","journal-title":"J Pain Res [Internet]"},{"issue":"2","key":"10.1016\/j.jclinane.2026.112156_bb0040","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/TA.0000000000002292","article-title":"Pain management in trauma patients affected by the opioid epidemic: a narrative review","volume":"87","author":"Karamchandani","year":"2019","journal-title":"J Trauma Acute Care Surg [Internet]"},{"key":"10.1016\/j.jclinane.2026.112156_bb0045","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.2147\/JPR.S509144","article-title":"Suzetrigine, a non-opioid NaV1.8 inhibitor with broad applicability for moderate-to-severe acute pain: a phase 3 single-arm study for surgical or non-surgical acute pain","volume":"18","author":"McCoun","year":"2025","journal-title":"J Pain Res [Internet]"},{"key":"10.1016\/j.jclinane.2026.112156_bb0050","article-title":"Insights into the voltage-gated sodium channel, NaV1.8, and its role in visceral pain perception","volume":"15","author":"Heinle","year":"2024","journal-title":"Front Pharmacol [Internet]"},{"issue":"Suppl. 3","key":"10.1016\/j.jclinane.2026.112156_bb0055","article-title":"The roles of sodium channels in nociception: implications for mechanisms of neuropathic pain","volume":"12","author":"Liu","year":"2011","journal-title":"Pain Med [Internet]"},{"issue":"2","key":"10.1016\/j.jclinane.2026.112156_bb0060","article-title":"Pharmacology and mechanism of action of suzetrigine, a potent and selective NaV1.8 pain signal inhibitor for the treatment of moderate to severe pain","volume":"14","author":"Osteen","year":"2025","journal-title":"Pain Ther [Internet]"},{"key":"10.1016\/j.jclinane.2026.112156_bb0065","series-title":"Pain management medications","author":"Milani","year":"2023"},{"key":"10.1016\/j.jclinane.2026.112156_bb0070","series-title":"FDA approves novel non-opioid treatment for moderate to severe acute pain","year":"2025"},{"issue":"1","key":"10.1016\/j.jclinane.2026.112156_bb0075","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.1503\/cmaj.109-5523","article-title":"A short history of pain management","volume":"190","author":"Collier","year":"2018","journal-title":"CMAJ [Internet]"},{"issue":"9","key":"10.1016\/j.jclinane.2026.112156_bb0080","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/jcph.1276","article-title":"Opioid therapy in acute and chronic pain","volume":"58","author":"Nafziger","year":"2018","journal-title":"J Clin Pharmacol [Internet]"},{"issue":"9","key":"10.1016\/j.jclinane.2026.112156_bb0085","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s11916-024-01265-z","article-title":"Emerging medications and strategies in acute pain management: evolving role of novel sodium and calcium channel blockers, peptide-based pharmacologic drugs, and non-medicinal methods","volume":"28","author":"Kaye","year":"2024","journal-title":"Curr Pain Headache Rep [Internet]"},{"issue":"3","key":"10.1016\/j.jclinane.2026.112156_bb0090","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/13543784.2020.1728254","article-title":"Neuropathic pain: preclinical and early clinical progress with voltage-gated sodium channel blockers","volume":"29","author":"Kushnarev","year":"2020","journal-title":"Expert Opin Investig Drugs [Internet]"},{"key":"10.1016\/j.jclinane.2026.112156_bb0095","article-title":"Towards structure-guided development of pain therapeutics targeting voltage-gated sodium channels","volume":"13","author":"Nguyen","year":"2022","journal-title":"Front Pharmacol [Internet]"},{"key":"10.1016\/j.jclinane.2026.112156_bb0100","article-title":"Towards structure-guided development of pain therapeutics targeting voltage-gated sodium channels","volume":"13","author":"Nguyen","year":"2022","journal-title":"Front Pharmacol [Internet]"},{"issue":"5","key":"10.1016\/j.jclinane.2026.112156_bb0105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa2209870","article-title":"Selective inhibition of Na V 1.8 with VX-548 for acute pain","volume":"389","author":"Jones","year":"2023","journal-title":"N Engl J Med [Internet]"},{"issue":"3","key":"10.1016\/j.jclinane.2026.112156_bb0110","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bja.2019.06.014","article-title":"Molecular mechanisms of action of systemic lidocaine in acute and chronic pain: a narrative review","volume":"123","author":"Hermanns","year":"2019","journal-title":"Br J Anaesth [Internet]"},{"key":"10.1016\/j.jclinane.2026.112156_bb0115","series-title":"Geriatric emergency medicine: principles and practice [internet]","first-page":"343","article-title":"Falls and fall prevention in older adults","author":"Carpenter","year":"2025"},{"issue":"11","key":"10.1016\/j.jclinane.2026.112156_bb0120","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41580-024-00763-7","article-title":"Structural biology and molecular pharmacology of voltage-gated ion channels","volume":"25","author":"Huang","year":"2024","journal-title":"Nat Rev Mol Cell Biol [Internet]"},{"issue":"11","key":"10.1016\/j.jclinane.2026.112156_bb0125","article-title":"Frontiers in acute pain management: emerging concepts in pain pathways and the role of VX-548 as a novel NaV1.8 inhibitor: a narrative review","volume":"28","author":"Kaye","year":"2024","journal-title":"Curr Pain Headache Rep [Internet]"},{"issue":"1","key":"10.1016\/j.jclinane.2026.112156_bb0130","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/1756283X15618131","article-title":"Nausea: a review of pathophysiology and therapeutics","volume":"9","author":"Singh","year":"2016","journal-title":"Therap Adv Gastroenterol [Internet]"},{"issue":"3","key":"10.1016\/j.jclinane.2026.112156_bb0135","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/07853899109148052","article-title":"The aetiology of dizziness and how to examine a dizzy patient","volume":"23","author":"Ojala","year":"1991","journal-title":"Ann Med [Internet]"},{"key":"10.1016\/j.jclinane.2026.112156_bb0140","first-page":"18","article-title":"Suzetrigine, a non-opioid Na V 1.8 inhibitor with broad applicability for moderate-to-severe acute pain: a phase 3 single-arm study for surgical or non-surgical acute pain on behalf of the VX-548-107 study team","volume":"2025","author":"Mccoun","year":"2025","journal-title":"J Pain Res [Internet]"},{"issue":"2","key":"10.1016\/j.jclinane.2026.112156_bb0145","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1152\/jn.2001.86.2.629","article-title":"Contribution of Nav 1.8 sodium channels to action potential electrogenesis in DRG neurons","volume":"86","author":"Renganathan","year":"2001","journal-title":"J Neurophysiol [Internet]"},{"issue":"6","key":"10.1016\/j.jclinane.2026.112156_bb0150","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10557-019-06931-8","article-title":"The role of Nav1.8 in cardiac electrophysiology\u2014a matter of the heart or the nerve?","volume":"33","author":"Odening","year":"2019","journal-title":"Cardiovasc Drugs Ther [Internet]"},{"issue":"5","key":"10.1016\/j.jclinane.2026.112156_bb0155","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1468-2982.2008.01800.x","article-title":"Neuropsychiatric side-effects of lidocaine: examples from the treatment of headache and a review","volume":"29","author":"Gil-Gouveia","year":"2009","journal-title":"Cephalalgia [Internet]"},{"issue":"6","key":"10.1016\/j.jclinane.2026.112156_bb0160","first-page":"1085","article-title":"Suzetrigine, a non-opioid NaV1.8 inhibitor for acute pain: results of two randomized, double-blind, placebo- and active-controlled phase 3 trials","volume":"142","author":"Bertoch","year":"2025","journal-title":"Anesthesiology"}],"container-title":["Journal of Clinical Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952818026000346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952818026000346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T19:19:56Z","timestamp":1777144796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952818026000346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"alternative-id":["S0952818026000346"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinane.2026.112156","relation":{},"ISSN":["0952-8180"],"issn-type":[{"value":"0952-8180","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of Suzetrigine (VX-548) for acute moderate to severe pain in adults; a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinane.2026.112156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112156"}}